Pharmaceutical firm Ipca LaboratoriesNSE -2.43 % Wednesday announced the acquisition of 80 per cent stake in US’ Bayshore Pharmaceuticals LLC by its subsidiary for USD 10.286 million (approx Rs 75.40 crore). The...
Takeda gets China’s approval for $62 billion Shire purchase
Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker. The...
Merck falls 14% in two days after CCI nod for acquisition by P&G
Shares of Merck were locked in the lower circuit for the second straight day, down 5% at Rs 3,064 per share on the BSE, after the Competition Commission of India (CCI) approved the acquisition of 51.8% stake in the...
Aurobindo Pharma acquires dermatology business from Sandoz in a $0.9bn cash deal
Hyderabad based Aurobindo pharmaNSE 5.15 % on Thursday announced that it will acquire the dermatology and oral solid business from Sandoz Inc, a subsidiary of Swiss drug maker NovartisNSE 0.00 % for an upfront purchase...
Domestic pharma players eye Bharat Serums acquisition
Domestic pharmaceutical companies CiplaNSE 0.08 %, Zydus Cadilla, Dr Reddy’s Laboratories and private equity fund Baring Asia are among those evaluating the acquisition of Mumbai-based vaccine maker Bharat Serums and...
Emergent BioSolutions to buy Narcan maker Adapt Pharma
Emergent BioSolutions Inc (EBS.N) said on Tuesday it would buy privately held Adapt Pharma, beefing up its portfolio with Narcan, the only FDA approved needle-free emergency opioid overdose treatment. Addiction to...
GSK seeks mid-September bids for $4 billion Indian Horlicks unit – sources
GlaxoSmithKline is seeking initial bids by mid-September for its India-focused Horlicks health nutrition business, which is expected to fetch more than $4 billion, two people familiar with the situation said on Tuesday...
OxyContin maker Purdue taps financial restructuring adviser – sources
OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its potential liabilities swell with a wave of lawsuits over the opioid addiction epidemic...
Carlyle in talks to invest $100 million in BDR Pharma
Private equity firm Carlyle is in talks with promoters of Mumbai-based BDR Pharma to invest $100 million in the drug company, the funding for which is expected to be used in expanding the company’s operations, according...
Perrigo board okays separation of prescription pharma business
Perrigo Company Plc said on Thursday its board approved a plan to separate its Prescription Pharmaceuticals (Rx) business after the generic drugmaker completed a review of its strategic portfolio. The board will...
Advent Has Held Talks to Sell Pharmacy Company Genoa
Private-equity firm Advent International has held talks with potential buyers about selling pharmacy company Genoa Healthcare, according to people familiar with the matter. Genoa, which could be worth about $2.5 billion...
Piramal set to demerge pharma, finance arms, list them on stock exchange
Billionaire businessman Ajay Piramal’s Piramal Enterprises (PEL) has finalised a plan to demerge its financial services and pharmaceutical businesses and list them on stock exchanges to unlock value in the two fast...
